Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.59 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.59 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.40 |
| ▸ | GRM6 | O15303 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.40 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.40 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1332934 | 0.95 | PTGS1 (0.61) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL3388582 | 0.91 | PTGS1 (0.57) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL4657010 | 0.90 | PTGS1 (0.56) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL5062960 | 0.89 | PTGS1 (0.55) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL3796919 | 0.88 | PTGS1 (0.54) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL3388427 | 0.88 | PTGS1 (0.54) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL2990987 | 0.87 | PTGS1 (0.53) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL5463061 | 0.86 | PTGS1 (0.61) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL1590483 | 0.86 | PTGS1 (0.52) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL3798413 | 0.86 | NOD1 (0.52) | PTGS1GSTK1GLO1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3661420-B1 | SCAVENGER PROTEIN(S) FOR IMPROVED PRESERVATION OF ANALYTE DETECTION SENSOR(S) AND METHOD(S) OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2023-08-23 | — | — | EP | claimed |
| US-11339419-B2 | Scavenger protein(s) for improved preservation of analyte detection sensor(s) and method(s) of use thereof | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-05-24 | — | — | US | claimed |
| EP-3661420-A1 | SCAVENGER PROTEIN(S) FOR IMPROVED PRESERVATION OF ANALYTE DETECTION SENSOR(S) AND METHOD(S) OF USE THEREOF | Siemens Healthcare Diagnostics Inc. (US) | 2020-06-10 | — | — | EP | claimed |
| US-20200140917-A1 | SCAVENGER PROTEIN(S) FOR IMPROVED PRESERVATION OF ANALYTE DETECTION SENSOR(S) AND METHOD(S) OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2020-05-07 | — | — | US | claimed |
| WO-2019027879-A1 | SCAVENGER PROTEIN(S) FOR IMPROVED PRESERVATION OF ANALYTE DETECTION SENSOR(S) AND METHOD(S) OF USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2019-02-07 | — | — | WO | claimed |
| US-8992945-B2 | Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds | UNIVERSITY OF TORONTO (CA) | 2015-03-31 | — | — | US | claimed |
| WO-2011003172-A1 | CONTROLLED NITRIC OXIDE DELIVERY FROM AQUEOUS S-NITROSOTHIOL CONJUGATED POLYMERS AND THEIR COMPLEXES | UNIVERSITY OF TORONTO (CA) | 2011-01-13 | — | — | WO | claimed |
| US-20100303891-A1 | SUPRAMACROMOLECULAR POLYMER COMPLEXES PROVIDING CONTROLLED NITRIC OXIDE RELEASE FOR HEALING WOUNDS | UNIVERSITY OF TORONTO (CA) | 2010-12-02 | — | — | US | claimed |
| EP-2201077-A1 | SUPRAMACRQMOLECULAR POLYMER COMPLEXES PROVIDING CONTROLLED NITRIC OXIDE RELEASE FOR HEALING WOUNDS | University of Toronto (CA) | 2010-06-30 | — | — | EP | claimed |
| WO-2009026680-A1 | SUPRAMACRQMOLECULAR POLYMER COMPLEXES PROVIDING CONTROLLED NITRIC OXIDE RELEASE FOR HEALING WOUNDS | LEE PING I (CA) | 2009-03-05 | — | — | WO | claimed |
| EP-1179055-A1 | NOVEL PHYTOCHELATIN SYNTHASES AND USES THEREFOR | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2002-02-13 | — | — | EP | claimed |
| WO-2000071695-A1 | NOVEL PHYTOCHELATIN SYNTHASES AND USES THEREFOR | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2000-11-30 | — | — | WO | claimed |
| EP-1015603-A2 | NEW PLANT GENES | RHONE-POULENC AGRICULTURE LTD. (GB) | 2000-07-05 | — | — | EP | claimed |
| WO-1999014337-A2 | NEW PLANT GENES | RHONE-POULENC AGRICULTURE LIMITED (GB) | 1999-03-25 | — | — | WO | claimed |
| US-20250388910-A1 | METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL | AGAIN BIO APS (DK) | 2025-12-25 | — | — | US | disclosed |
| US-20250320531-A1 | MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 1,4-BUTANEDIOL RELATED THERETO | AGAIN BIO APS (DK) | 2025-10-16 | — | — | US | disclosed |
| US-12398396-B2 | Methods for enhancing microbial production of specific length fatty alcohols in the presence of methanol | GENOMATICA, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| EP-1015603-A2 | NEW PLANT GENES | RHONE-POULENC AGRICULTURE LTD. (GB) | 2000-07-05 | — | — | EP | disclosed |
| EP-0986955-A1 | Conjugates of glutathione as signal molecules | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH (DE) | 2000-03-22 | — | — | EP | disclosed |
| WO-1999014337-A2 | NEW PLANT GENES | RHONE-POULENC AGRICULTURE LIMITED (GB) | 1999-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388910-A1 | METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL | ADH5, ADH1C, ADH1A | PTGS1 1485/4885GSTK1 1371/4885GLO1 343/4885 |
| US-20100303891-A1 | SUPRAMACROMOLECULAR POLYMER COMPLEXES PROVIDING CONTROLLED NITRIC OXIDE RELEASE FOR HEALING WOUNDS | NOS3, NOS1, NOS2 | PTGS1 292/4885GSTK1 1644/4885GLO1 836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.